Chemplast Sanmar IPO Subscription Day-2
Last Updated: 13th December 2022 - 11:23 pm
The Rs.3,850 crore IPO of Chemplast Sanmar, consisting of Rs.1,300 crore fresh issue and Rs.2,550 crore OFS, was still only partially subscribed on Day-2. As per the combined bid details put out by BSE at the close of Day-2 of the issue, Chemplast Sanmar IPO was subscribed 0.26X overall, with bulk of the demand coming from the retail segment. The issue closes on 12th August.
In terms of numbers, out of the 399.53 lakh shares on offer in the IPO, Chemplast Sanmar saw applications for 103.37 lakh shares. This implies an overall subscription of 0.26X. The granular break-up of subscriptions were tilted in favour of retail investors.
Chemplast Sanmar IPO Subscription Status Day 2
Category | Subscription Status |
Qualified Institutional (QIB) | 0.02 Times |
Non-Institutional (NII) | 0.06 Times |
Retail Individual | 1.29 Times |
Total | 0.26 Times |
QIB Portion
The QIB portion virtually got hardly any response on Day-2. On 09 Aug, Chemplast Sanmar did an anchor placement worth Rs.1,733 crore. QIB portion, net of anchor allocation, was subscribed 0.02X (getting applications for 3.42 lakh shares against the available quota of 217.92 lakh shares) at the close of Day-2.
HNI Portion
The HNI portion got subscribed 0.06X (getting applications for 6.13 lakh shares against the quota of 108.96 lakh shares). However, funded applications and corporate applications typically come in on the last day only.
Retail Individuals
The retail portion got subscribed 1.29X at the close of Day-2, showing reasonable retail appetite. Out of the 72.64 lakh shares on offer, valid bids were received for 93.82 lakh shares, of which bids for 76.95 lakh shares were at the cut-off price. The IPO is priced in the band of (Rs.530-Rs.541) and closes for subscription on 12th August.
Also Read:
Trending on 5paisa
Discover more of what matters to you.
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.